References
- Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811–21.
- Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:170–80.
- Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, . Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372:1953–61.
- Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, . SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008;40:430–6.
- Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, . Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
- Hu M, Lui SS, Mak VW, Chu TT, Lee VW, Poon EW, . Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. Pharmacogenet Genomics 2010;20:634–7.
- Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62.
- Cummings N, Dyer TD, Kotea N, Kowlessur S, Chitson P, Zimmet P, . Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate. Eur J Hum Genet 2010; 18:1243–7.
- Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004;1681:53–8.